Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: A cross sectional study
Françoise Lunel‐Fabiani(Université d'Angers), M. Rosenheim(Sorbonne Université), Frédéric Le Gal(Sorbonne Université), Abdellahi Ould Amar(Université de Nouakchott), Alexandra Ducancelle, Faryal Malick(Université de Nouakchott), Ségolène Brichler(Inserm), Mohamed Aye(Université de Nouakchott), Emmanuel Gordien(Inserm), Wael Mansour(Universität Hamburg), Lô Baïdy(Université de Nouakchott), Pascal Veillon(Université d'Angers)
Cited by 52
Related Papers
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a <i>Deltavirus</i> Genus of at Least Seven Major Clades
|Journal of Virology|2004|221
Eighth Major Clade for Hepatitis Delta Virus
|Emerging infectious diseases|2006|206